0001035354 2026-09-11 2026-09-11 0001035354 1 2026-09-11 2026-09-11 0001035354 2 2026-09-11 2026-09-11 iso4217:USD pure shares S-1 S-1 EX-FILING FEES 0001035354 Eloxx Pharmaceuticals, Inc. N/A N/A S-1 Eloxx Pharmaceuticals, Inc. false Equity Common Stock, par value $0.01 per share true 600000 16.40 9840000.00 0.0001381 1358.90 false Equity Shares of Common Stock issuable upon exercise of Pre-Funded Warrants true 4358919 16.40 71486271.60 0.0001381 9872.25 81326271.60 11231.15 0.00 0.00 11231.15 Represents the shares of common stock (the "common stock") of Eloxx Pharmaceuticals, Inc. (the "Registrant") that will be offered for resale by the selling stockholders pursuant to the prospectus to which this exhibit is attached. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall also cover an indeterminate number of shares of common stock that may be issued and resold resulting from stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder. The proposed maximum offering price per share has been estimated solely for the purpose of calculating the registration fee. The registration fee has been calculated in accordance with Rule 457(c) under the Securities Act based on the average high and low prices reported for the Registrant's common stock on September 10, 2026. See Offering Note 1. Each Pre-Funded Warrant is exercisable for one share of Common Stock. Accordingly, the proposed maximum aggregate offering price of the shares of Common Stock underlying the Pre-Funded Warrants is $71,486,271.60.